TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Kuick Research Highlights Explosive Growth and M&A Momentum In Global Multispecific Antibody Market

Benzinga Logo Benzinga By Neeraj Chawla
Kuick Research Highlights Explosive Growth and M&A Momentum In Global Multispecific Antibody Market

Kuick Research reports the global multispecific antibodies market is experiencing rapid growth, with market potential exceeding $50 billion by 2030, driven by innovative biologics targeting multiple disease pathways across oncology, hematology, and autoimmune diseases.

Insights
CHYM   neutral

Mentioned as a competitive fintech company in the US market, no specific performance details provided


AMGN   positive

Early entrant with successful multispecific antibody Blincyto, demonstrating first-mover advantage